|
| Wednesday, 27 July 2011, 10:00 HKT/SGT | |
| |  | |
Source: A*STAR | |
|
|
|
SINGAPORE, July 27, 2011 - (ACN Newswire) - The Industrial Consortium On Nanoimprint (ICON), which is helmed by the Institute of Materials Research and Engineering (IMRE), a research institute of Singapore's Agency for Science, Technology and Research (A*STAR), is ready to put roll-to-roll nanoimprint manufacturing to the test. This manufacturing process can easily and quickly mass produce films and surfaces with nanometer-scale textures for a host of new applications in biomedical devices, optical films, plastic electronics and flexible solar cells.
 | | Prototype Tools for Mass Producing Nanostructures to Launch in Singapore |
Nanoimprinted structures and components are being used in items such as anti-reflection films, and solar cells. However, their impact in consumer products is limited as viable manufacturing processes to scale-up the production of such nanostructures is lacking. IMRE and its partners in ICON are planning to manufacture the structures, using a roll to roll process. This fast, mass production method can create large area nanostructured components, opening the way for new consumer applications not previously conceptualised or economically feasible.
Roll-to-roll imprinting is the third industry-themed project by ICON that includes local and international partners such as Solves Innovative Technology Pte Ltd (Singapore), Advanced Technologies and Regenerative Medicine, LLC (ATRM) (USA), Young Chang Chemical Co. Ltd (South Korea), EV Group (Austria), Micro Resist Technology GmbH (Germany) and NTT Advanced Technology Corporation (Japan). The partners who are raw material providers, tool-makers, and end-users represent the entire value chain for producing nano-structures and putting them to use. Some of the applications that the consortium hopes to harness with roll-to-roll nanoimprint include anti-fouling surfaces, anti-reflection films to enhance the efficiency of solar cells, wire-grid polarisers, and optical films for flat panel displays.
"The roll-to-roll nanoimprinting technique is a crucial centerpiece in ICON's plan to complete the value chain for harnessing the true potential of our bio-mimetic multifunctional nanoimprint technology surfaces," said Dr Low Hong Yee, an IMRE senior scientist who heads the team developing the roll-to-roll nanoimprint technology. "With this method we can merge nanoimprint technologies into real-world applications and on an industrial scale," explained Dr Low, adding that the engineered materials that are produced can be made for a variety of applications. For example, nanostructures can be used to mimic patterns of surfaces found in nature to endow the synthetic surfaces with properties such as inherent colour effects, tack-free adhesion to surfaces, water-proofing and anti-reflectivity.
ICON will be introducing two types of roll-to-roll techniques - a thermal and a UV-based version. The thermal method makes patterns on the substrate directly, can accommodate a variety of plastics for different applications, and is ideally suited for the fabrication of micro- and nano-fluidic devices, biochemical assays as well as other biomedical applications. The UV technique allows quicker processing because it is a room temperature process, and offers the advantage of fabricating the nanostructures on cross-linkable resins, thus imparting higher thermal and mechanical stability to the imprinted products.
"The joint collaborative work with ICON to design and build the first roll-to-roll thermal nanoimprinting machine gives us the chance to work with other industry partners on how this equipment can be applied," commented Mr Hermann Waltl, Executive Sales and Customer Support Director of EV Group, whose global headquarters is in Austria, on the roll-to-roll thermal nanoimprinter that the company has jointly developed with ICON.
"ICON provides us the opportunity to hear directly from industry about their needs so that we can customise future roll-to-roll equipment designs to specific industry requirements. ICON is all about transitioning scalable nanoimprinting techniques out of the laboratory and into the marketplace. Roll-to-roll strategies certainly fit the bill here. A lot of companies are watching the progress closely," said Mr Koh Teng Hwee, Managing Director of Solves, a small and medium enterprise that had worked with IMRE to develop the roll-to-roll UV nanoimprinting tool.
"This partnership on roll-to-roll nanoimprinting enhances our competitiveness in the global arena, particularly in helping us create new functional and patterned film technologies for displays and solar cell applications," said Mr Kim Woo Yong, Global Marketing Director of Young Chang Chemical Co. Ltd, South Korea.
"We are happy to be involved in this groundbreaking project that will bring a new dimension to our core business and help us develop materials for a greater variety of markets and industries," said Mrs Gabi Gruetzner, Managing Director of Micro Resist Technology GmbH (Germany), a company that specialises in providing photoresists and polymers for micro and nanolithography.
ICON is Singapore's first nanotechnology consortium that encourages companies to adopt versatile, industry-ready nanoimprinting technology that can bring products to the market through sustainable manufacturing. Nanoimprint technology produces nanometer-sized structures of greater complexity using fewer processing steps, while minimising wastage of materials. It has evolved from a lithography technology for the semiconductor industry to a platform process technology that can be adapted to a wide range of applications. The members of ICON will gain first-hand access to these new technologies by working on joint projects to develop new products and applications that can potentially have huge savings in R&D.
About the Institute of Materials Research and Engineering (IMRE)
The Institute of Materials Research and Engineering (IMRE) is a research institute of the Agency for Science, Technology and Research (A*STAR). The Institute has capabilities in materials analysis & characterisation, design & growth, patterning & fabrication, and synthesis & integration. We house a range of state-of-the-art equipment for materials research including development, processing and characterisation. IMRE conducts a wide range of research, which includes novel materials for organic solar cells, photovoltaics, printed electronics, catalysis, bio-mimetics, microfluidics, quantum dots, heterostructures, sustainable materials, atom technology, etc. We collaborate actively with other research institutes, universities, public bodies, and a wide spectrum of industrial companies, both globally and locally. For more information about IMRE, please visit www.imre.a-star.edu.sg.
Contact:
Mr Eugene Low
Manager, Corporate Communications
for Institute of Materials Research and Engineering (IMRE)
DID: +65 6874 8491
Mobile: +65 9230 9235
Email: loweom@scei.a-star.edu.sg
For technical enquiries, please contact:
Dr Low Hong Yee
Senior Scientist II
Institute of Materials Research and Engineering (IMRE)
DID: +65 6874 8133
Email: hy-low@imre.a-star.edu.sg
Topic: New Service
Source: A*STAR
Sectors: Engineering, Chemicals, Spec.Chem, Science & Nanotech
http://www.acnnewswire.com
From the Asia Corporate News Network
Copyright © 2024 ACN Newswire. All rights reserved. A division of Asia Corporate News Network.
|
|
|
|
|
|
|
| A*STAR |
| Dec 6, 2022 14:00 HKT/SGT |
|
Global pharma giants partner Singapore researchers to boost innovation in biologics and vaccines manufacturing |
| June 2, 2022 21:00 HKT/SGT |
|
Boehringer Ingelheim Enters Global Licensing Agreement to Develop and Commercialize Innovative Antibodies from A*STAR for Targeted Cancer Therapies |
| June 2, 2022 21:00 HKT/SGT |
|
Boehringer Ingelheim Enters Global Licensing Agreement to Develop and Commercialize Innovative Antibodies from A*STAR for Targeted Cancer Therapies |
| Sept 30, 2021 16:00 HKT/SGT |
|
A*STAR and Local SME Work with Vaccination Centres to Deploy AVID System for Filling Syringes |
| July 31, 2020 08:00 HKT/SGT |
|
Singapore Cancer Drug ETC-159 Advances Further in Clinical Trials |
| July 24, 2020 17:00 HKT/SGT |
|
MP Biomedicals and A*STAR Co-Develop Rapid Antibody Test Kit for SARS-CoV-2 |
| Oct 22, 2019 04:00 HKT/SGT |
|
Fujitsu, SMU and A*STAR Launch Digital Platform Experimentation Project using Quantum-Inspired Computing and Deep Learning Technology |
| June 28, 2019 08:00 HKT/SGT |
|
Singapore's Drug Development Efforts Given Additional Momentum with National Platforms |
| Apr 5, 2019 18:00 HKT/SGT |
|
Passing of Dr Sydney Brenner, Nobel Laureate, Renowned Pioneer in Molecular Biology, A*Star Senior Fellow |
| Jan 21, 2019 13:00 HKT/SGT |
|
Branched-Chain Amino Acids Found to Regulate the Development and Progression of Cancer |
| More news >> |
 |
|
|
|
